Evidence map›Paper›PMID 42943299›Full record

ArticlePharmaceuticals (Basel, Switzerland)2026

Network Pharmacology-Assisted Multi-Omics Analysis of Gut Microbiota-Host Metabolic Remodeling and Hepatic HPD/GSTM3-Associated Redox Responses Following Shanqijing Treatment in STZ-Induced Diabetic Mice.

Xiangpeng Kong, Haiqin Ren, Jiani He, Ke Pei, Hui Zhang, Haixin Liu, Zhuqing Song, Yujia Liu, Zhuoyang Wei, Yiwei Chen and 6 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Pharmaceuticals (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Xiangpeng KongInstitute of Pharmaceutical & Food Engineering, Shanxi University of Chinese Medicine, Jinzhong 030619, China.ORCID 0000-0003-2013-1131
Haiqin RenSchool of Pharmacy, Harbin University of Commerce, Harbin 150076, China.ORCID 0000-0002-4266-9752
Jiani HeInstitute of Pharmaceutical & Food Engineering, Shanxi University of Chinese Medicine, Jinzhong 030619, China.
Ke PeiInstitute of Pharmaceutical & Food Engineering, Shanxi University of Chinese Medicine, Jinzhong 030619, China.
Hui ZhangSchool of Pharmacy, Faculty of Medicine, Macau University of Science and Technology, Macau SAR, China.
Haixin LiuInstitute of Pharmaceutical & Food Engineering, Shanxi University of Chinese Medicine, Jinzhong 030619, China.
Zhuqing SongInstitute of Pharmaceutical & Food Engineering, Shanxi University of Chinese Medicine, Jinzhong 030619, China.
Yujia LiuSchool of Life Sciences and Medical Engineering, Anhui University, Hefei 230601, China.
Zhuoyang WeiThe Third Clinical College, Shanxi University of Chinese Medicine, Jinzhong 030619, China.
Yiwei ChenInstitute of Pharmaceutical & Food Engineering, Shanxi University of Chinese Medicine, Jinzhong 030619, China.
Kaifan YangInstitute of Pharmaceutical & Food Engineering, Shanxi University of Chinese Medicine, Jinzhong 030619, China.
Wenhui DengShanxi Administration for Market Regulation, Taiyuan 030012, China.
Yuxia GuoInstitute of Pharmaceutical & Food Engineering, Shanxi University of Chinese Medicine, Jinzhong 030619, China.
Huifeng LiInstitute of Pharmaceutical & Food Engineering, Shanxi University of Chinese Medicine, Jinzhong 030619, China.
Yuanbiao QiaoShanxi Laboratory for the Development of New TCM Products, Shanxi University of Chinese Medicine, Jinzhong 030619, China.
Miaorong PeiInstitute of Pharmaceutical & Food Engineering, Shanxi University of Chinese Medicine, Jinzhong 030619, China.

Funding

Shanxi Provincial Department of Science and Technology 202102130501006Shanxi Provincial Education Department J20241079Shanxi Provincial Health Commission 2022081Shanxi University of Traditional Chinese Medicine 2020PY-YC-05, 2024PY-CXY-008
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

gut microbiotahepatic redox responseHPD/GSTM3multi-omicsnatural productsnetwork pharmacologyserum metabolomicsShanqijingshort-chain fatty acids (SCFAs)type 1 diabetes mellitus (T1DM)

Identifiers

PMID42943299
PMCPMC13708638

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.